Quality of End-of-Life Care for Children With Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChildren's Oncology Group
About this trial
This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end-of-life care. The data collected from this study may help researchers develop a model for identifying patients at risk of low-quality end-of-life care as well as recommendations for potential future interventions.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Must be deceased
< 18 years old at time of death
Diagnosed with any oncologic condition
History of enrollment on Stratum 1 of APEC14B1, Project:EveryChild
Disqualifiers
None
Trial population
Bereaved parents of an eligible deceased COG registered index child patient previously enrolled on Stratum 1 of APEC14B1, Project:EveryChild
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
2,425 Participants
are divided into 2 treatment groupsGroup A: Observational part 11 intervention
Group B: Observational part 21 intervention
Trial outcomes
Primary outcomes
1
Quality of end of life (EOL) care
Is a composite measure evaluated as the percent of applicable measures with high-quality care for each patient. For each child, will calculate the percent of measures applicable to that patient for which they met the criteria for high-quality care. Of note, not all measures will apply to every patient (e.g., assessment of sibling support will only apply to those with siblings). EOL quality will be treated as a continuous variable.
Time frame
3 months to 2 years after the child's deathSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov